Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: China

Fortune SGAM Pharmaceutical and Bios Selection Fund

+ Add to Watchlist

FSPHBIS:CH

1.45 CNY 0.01 0.84%

As of 10:54:26 ET on 03/05/2015.

Snapshot for Fortune SGAM Pharmaceutical and Bios Selection Fund (FSPHBIS)

Year To Date: +17.40% 3-Month: +7.96% 3-Year: +12.82% 52-Week Range: 1.12 - 1.44
1-Month: +8.29% 1-Year: +11.74% 5-Year: - Beta vs : -

Mutual Fund Chart for FSPHBIS

No chart data available.
  • FSPHBIS:CH 1.45
  • 1M
  • 1Y
Interactive FSPHBIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FSPHBIS

Fortune SGAM Pharmaceutical and Bios Selection Fund is an open-ended fund incorporated in China. The Fund seeks to achieve long-term stable return via controlling risk and liquidity. The Fund invests at least 80% of its total equity investments into pharmaceutical and bios companies listed in China.

Inception Date: 03-02-2012 Telephone: 86-21-38505888 Tel
Managers: FAN HONG-BING / WANG ZHI-WEI
Web Site: www.fsfund.com

Fundamentals for FSPHBIS

NAV (on 2015-03-05) 1.45
Assets (M) (on 2014-12-31) 780.63
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 1,000.00

Dividends for FSPHBIS

No dividends reported

Fees & Expenses for FSPHBIS

Front Load 1.50
Back Load 1.50
Current Mgmt Fee 1.50
Redemption Fee 1.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FSPHBIS

Filing Date: 06/30/2014
Name Position Value % of Total
Xiangxue Pharmaceutical Co Ltd 4,145,491 86,098,653 7.180%
Sinocare Inc 1,409,604 56,243,200 4.690%
Huadong Medicine Co Ltd 684,368 36,955,872 3.082%
Guizhou Yibai Pharmaceutical C 891,416 36,663,940 3.057%
China National Accord Medicine 900,441 35,972,618 3.000%
Shanghai Fosun Pharmaceutical 1,780,375 35,945,771 2.997%
Shanghai Tofflon Science & Tec 1,436,081 35,262,738 2.941%
Zhejiang Hisun Pharmaceutical 2,343,493 34,754,001 2.898%
Aier Eye Hospital Group Co Ltd 1,423,857 34,656,679 2.890%
Shanghai Pharmaceuticals Holdi 2,547,945 31,670,956 2.641%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil